Effects of vitamin D deficiency and combination antiretroviral therapy on bone in HIV-positive patients
Myeloid dendritic cells isolated from tissues of SIV-infected Rhesus macaques promote the induction of regulatory T cells
Prime-boost regimens with adjuvanted synthetic long peptides elicit T cells and antibodies to conserved regions of HIV-1 in macaques
Incidence of low and high-energy fractures in persons with and without HIV infection
Vitamin D deficiency and persistent proteinuria among HIV-infected and uninfected injection drug users
Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatment
Long-term exposure to combination antiretroviral therapy and risk of death from specific causes
Extended prophylaxis with nevirapine and cotrimoxazole among HIV-exposed uninfected infants is well tolerated
Projected life expectancy of people with HIV according to timing of diagnosis
Use of the community viral load as a population-based biomarker of HIV burden
Cost-effectiveness of combination therapy with etravirine in treatment-experienced adults with HIV-1 infection
Mortality and loss to follow-up in the first year of ART
The effects of injectable hormonal contraceptives on HIV seroconversion and on sexually transmitted infections
Proximate context of gender-unequal norms and women's HIV risk in sub-Saharan Africa
Bacterial vaginosis, HIV serostatus and T-cell subset distribution in a cohort of East African commercial sex workers
Regulatory T cells are converts in simian immunodeficiency virus infection
Reply to ‘pharmacokinetic concerns related to darunavir/ritonavir plus raltegravir combination therapy trial’
Pharmacokinetic concerns related to the AIDS Clinical Trial Group (ACTG) A5262 trial
Epstein–Barr virus associated colitis in an HIV-infected patient